Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs

(2021) Simon Valentin et al.   EUROPEAN RESPIRATORY JOURNAL

COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension

(2021) Marius M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

Familial pulmonary arterial hypertension by KDR heterozygous loss of function

(2020) Mélanie Eyries et al.   EUROPEAN RESPIRATORY JOURNAL

Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension

(2020) Robert A. Lewis et al.   EUROPEAN RESPIRATORY JOURNAL

Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

(2020) Marius M. Hoeper et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

(2018) Gérald Simonneau et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary hypertension in chronic lung disease and hypoxia

(2018) Steven D. Nathan et al.   EUROPEAN RESPIRATORY JOURNAL

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension

(2017) David Kylhammar et al.   EUROPEAN HEART JOURNAL

Is there a vanishing pulmonary capillary syndrome?

(2017) Marius M Hoeper et al.   Lancet Respiratory Medicine

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study

(2017) David Montani et al.   Lancet Respiratory Medicine

Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction

(2016) Marius M. Hoeper et al.   JACC-Heart Failure

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Selexipag for the Treatment of Pulmonary Arterial Hypertension

(2015) Olivier Sitbon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

(2015) Nazzareno Galiè et al.   NEW ENGLAND JOURNAL OF MEDICINE

Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses

(2013) Pia Trip et al.   EUROPEAN RESPIRATORY JOURNAL

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

(2013) Tomás Pulido et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension

(2012) Yi Ling et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry

(2012) Marius M. Hoeper et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice

(2011) Michael Seimetz et al.   CELL

ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre

(2011) J. Hurdman et al.   EUROPEAN RESPIRATORY JOURNAL

Tobacco Smoke: A Risk Factor for Pulmonary Arterial Hypertension?

(2010) Regula Schiess et al.   CHEST

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Nazzareno Galiè et al.   CIRCULATION